A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies

被引：2
|
作者：
Dang, Anhthu [1 ]
Knee, Deborah [2 ]
Wang, Cui Ying [2 ]
Gao, Feng [2 ]
Liu, Guoxun [2 ]
Briones, Sergio [2 ]
Coulson, Michelle [3 ]
Makofske, Jessica [1 ]
Mansfield, Keith [1 ]
Liu, May [1 ]
Mulvey, Tanya [1 ]
Meseck, Emily K. [4 ]
Woolfenden, Steve [1 ]
Buchanan, Sean G. [2 ]
Steensma, David [1 ]
Askoxylakis, Vasileios [1 ]
机构：
[1] Novartis Inst BioMed Res, Cambridge, MA USA
[2] Novartis Inst BioMed Res, San Diego, CA USA
[3] Novartis Pharmaceut, Preclin Safety, Cambridge, MA USA
[4] Novartis Pharmaceut, Preclin Safety, E Hanover, NJ USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159910
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11564 / 11565
页数：2
相关论文
共 50 条
  • [1] A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies
    Kim, S. Y.
    Theunissen, J-W
    Balibalos, J.
    Liao-Chan, S.
    Babcock, M. C.
    Wong, T.
    Cairns, B.
    Gonzalez, D.
    van der Horst, E. H.
    Perez, M.
    Levashova, Z.
    Chinn, L.
    D'Alessio, J. A.
    Flory, M.
    Bermudez, A.
    Jackson, D. Y.
    Ha, E.
    Monteon, J.
    Bruhns, M. F.
    Chen, G.
    Migone, T-S
    BLOOD CANCER JOURNAL, 2015, 5 : e316 - e316
  • [2] A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies
    S Y Kim
    J-W Theunissen
    J Balibalos
    S Liao-Chan
    M C Babcock
    T Wong
    B Cairns
    D Gonzalez
    E H van der Horst
    M Perez
    Z Levashova
    L Chinn
    J A D‘Alessio
    M Flory
    A Bermudez
    D Y Jackson
    E Ha
    J Monteon
    M F Bruhns
    G Chen
    T-S Migone
    Blood Cancer Journal, 2015, 5 : e316 - e316
  • [3] Development of a novel antibody-drug conjugate for refractory lymphoid malignancies
    Arita, Daigo
    Saijho, Sinji
    Matsumura, Yasuhiro
    Yasunaga, Masahiro
    CANCER SCIENCE, 2018, 109 : 389 - 389
  • [4] Epratuzumab-SN-38: A New Antibody-Drug Conjugate for the Therapy of Hematologic Malignancies
    Sharkey, Robert M.
    Govindan, Serengulam V.
    Cardillo, Thomas M.
    Goldenberg, David M.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (01) : 224 - 234
  • [5] Immunoregulation by IL-7R-targeting antibody-drug conjugate
    Yang, Shiqi
    Yasunaga, Masahiro
    Anzai, Takahiro
    CANCER SCIENCE, 2023, 114 : 1990 - 1990
  • [6] Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
    FitzGerald, David J.
    Wayne, Alan S.
    Kreitman, Robert J.
    Pastan, Ira
    CANCER RESEARCH, 2011, 71 (20) : 6300 - 6309
  • [7] Immunoregulation by IL-7R-targeting antibody-drug conjugate
    Yang, Shiqi
    Yasunaga, Masahiro
    Anzai, Takahiro
    CANCER SCIENCE, 2024, 115 : 619 - 619
  • [8] Immunoregulation by IL-7R-targeting antibody-drug conjugate
    Yang, Shiqi
    Yasunaga, Masahiro
    Manabe, Shino
    CANCER SCIENCE, 2022, 113 : 399 - 399
  • [9] Targeting FZD7-positive cancers using a novel antibody-drug conjugate.
    Do, Myan
    Wu, Christina C.
    Adams, Stephen
    Carson, Dennis
    Advani, Sunil
    Willert, Karl
    CANCER RESEARCH, 2021, 81 (13)
  • [10] Preclinical development of a novel antibody-drug conjugate targeting "cold" tumors
    Kaplan, Angelo
    Attanasio, Nickolas
    Do, To Uyen T.
    Swaminathan, Sudha
    Bisht, Arnima
    Lou, San Lin
    Allen, Jason
    Boyd, Robert
    Ackroyd, James E.
    Feldman, Gleb
    Rohlff, Christian
    Dusek, Rachel L.
    CANCER RESEARCH, 2018, 78 (13)
12345